The Prevalence and Fetal and Maternal Outcome of Overt and Subclinical Hypothyroidism among Pregnant Women; A Cross-sectional Study

Lalooei, Afsaneh; Beheshti, Fatemeh; Khalili, Nahid; Hashemi, Seyedeh Razieh

doi:10.30477/cjm.2022.332607.1040

The Prevalence and Fetal and Maternal Outcome of Overt and Subclinical Hypothyroidism among Pregnant Women; A Cross-sectional Study

Document Type : Original Article

Authors

Afsaneh Lalooei ¹

Fatemeh Beheshti ²

Nahid Khalili ³

Seyedeh Razieh Hashemi ¹

¹ Obstetrics and Gynecology Department, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

² Student Research Committee, Baqiyatallah University of medical sciences, Tehran, Iran.

³ Endocrinology Department, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

10.30477/cjm.2022.332607.1040

Abstract

Abstract:
Introduction: Maternal thyroid dysfunction during pregnancy and its relationship with pregnancy outcomes has been under consideration in last decades. Hypothyroidism, especially subclinical hypothyroidism, is the most common type of thyroid dysfunction among women in reproductive age. We aimed to evaluate the prevalence and maternal/fetal outcomes of these two conditions among Iranian pregnant women.
Methods: This cross-sectional study was conducted between January and July 2016 at Baqiyatallah hospital, Tehran, Iran. All pregnant women attending to Baqiyatallah Obstetrics and Gynecology clinic during study period were assessed for eligibility. Demographic information as well as information on parity, repeated abortion, history of infertility, size of thyroid and history of autoimmune diseases were recorded in a pre-designed checklist. TSH and T4 levels were measured by Chemiluminescence method and recorded in related forms.
Results: Eventually 500 patients with a mean age of 27.77±4 years underwent analysis. Thyroid dysfunctions had a prevalence of 30.2% (151 cases). Of this proportion 143 patients (28.6%) had hypothyroidism from which 56(11.2%) patients had clinical and 59(11.8%) had subclinical hypothyroidism. In this study, 258 individuals had deliveries with one abortion in euthyroid and one in low-TSH group.
Conclusion: In conclusion our findings showed that hypothyroidism has a prevalence of 28.6% among Iranian pregnant women attending to our hospital. Also we found that subclinical hypothyroidism is more prevalent than overt hypothyroidism. The results showed that thyroid dysfunction is more prevalent in infants with maternal impaired thyroid function tests.

Keywords

Pregnancy

Hypothyroidism

Subclinical hypothyroidism

Prevalence

Overt hypothyroidism

Subjects

Epidemiology

Reference:
1. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstetrics and gynecology. 2008;112(1):85.
2. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2010;95(9):E44-E8.
3. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. The Journal of Clinical Endocrinology & Metabolism. 2011;96(6):E920-E4.
4. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63-8.
5. Allan W, Haddow J, Palomaki G, Williams J, Mitchell M, Hermos R, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. Journal of medical screening. 2000;7(3):127-30.
6. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. The Journal of Clinical Endocrinology & Metabolism. 2009;94(1):21-5.
7. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstetrics & Gynecology. 2006;107(2, Part 1):337-41.
8. Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PloS one. 2017;12(4):e0175708.
9. Sepasi F, Rashidian T, Shokri M, Badfar G, Kazemi F, Azami M. Thyroid dysfunction in Iranian pregnant women: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 2020;20(1):1-15.
10. Teng W, Shan Z, Patil-Sisodia K, Cooper DS. Hypothyroidism in pregnancy. The lancet Diabetes & endocrinology. 2013;1(3):228-37.
11. Nambiar V, Jagtap VS, Sarathi V, Lila AR, Kamalanathan S, Bandgar TR, et al. Prevalence and impact of thyroid disorders on maternal outcome in Asian-Indian pregnant women. Journal of thyroid research. 2011;2011.
12. Carty DM, Doogan F, Welsh P, Dominiczak AF, Delles C. Thyroid stimulating hormone (TSH)≥ 2.5 mU/l in early pregnancy: Prevalence and subsequent outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017;210:366-9.
13. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al. The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. European Journal of Endocrinology. 2011;164(2):263-8.
14. Su P-Y, Huang K, Hao J-H, Xu Y-Q, Yan S-Q, Li T, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10):3234-41.